Search Results - "Mesa Lopez, Dayrelis T"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Rac signaling drives clear cell renal carcinoma tumor growth by priming the tumor microenvironment for an angiogenic switch by Goka, Erik T, Chaturvedi, Pallavi, Mesa Lopez, Dayrelis T, Lippman, Marc E

    Published in Molecular cancer therapeutics (01-07-2020)
    “…Clear cell renal cell carcinoma (ccRCC) remains a common cause of cancer mortality. Better understanding of ccRCC molecular drivers resulted in the development…”
    Get full text
    Journal Article
  2. 2

    RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer by Goka, Erik T, Chaturvedi, Pallavi, Lopez, Dayrelis T Mesa, Garza, Adriana De La, Lippman, Marc E

    Published in Molecular cancer therapeutics (01-05-2019)
    “…Resistance to chemotherapy represents a major limitation in the treatment of colorectal cancer. Novel strategies to circumvent resistance are critical to…”
    Get full text
    Journal Article
  3. 3

    Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival by Goka, Erik T, Mesa Lopez, Dayrelis T, Lippman, Marc E

    Published in Molecular cancer therapeutics (01-06-2021)
    “…Prostate cancer remains a common cause of cancer mortality in men. Initially, cancers are dependent of androgens for growth and survival. First line therapies…”
    Get full text
    Journal Article
  4. 4

    Abstract P3-10-13: Rac inhibition as an alternative approach to treating hormone dependent breast cancer by Goka, Erik T, Sun, Jun, Lopez, Dayrelis T Mesa, Lippman, Marc E

    Published in Cancer research (Chicago, Ill.) (15-02-2020)
    “…Hormone positive breast cancer remains one of the leading causes of cancer mortality in women. Despite the advancement in endocrine therapy and the addition of…”
    Get full text
    Journal Article